The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.d

Organizing pneumonia pattern (an area or areas of consolidation on imaging)

Publications

Carvalho JG, Fernandes C, França M

Organizing pneumonia secondary to amiodarone treatment.

Heliyon. 2022;8(9):e10630

Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V

Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.

Chest. 2011;139(4):893-900

Fernández-Ruiz M, Guerra-Vales JM, Villena-Garrido V

[Bronchiolitis obliterans with organized pneumonia secondary to amiodarone: presentation of two cases with different therapeutic approach].

Revista clinica espanola. 2009;209(11):568-9

Polverosi R, Maffesanti M, Dalpiaz G

Organizing pneumonia: typical and atypical HRCT patterns.

La Radiologia medica. 2006;111(2):202-12

Oymak FS, Demirbaş HM, Mavili E, Akgun H, Gulmez I, Demir R, Ozesmi M

Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases.

Respiration; international review of thoracic diseases. 2005;72(3):254-62

Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD

Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage.

Archives of pathology & laboratory medicine. 2002;126(9):1064-70

Antón Aranda E, Alkiza Basañez R, Laplaza Jiménez Y

Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment.

The Netherlands journal of medicine. 1998;53(3):109-12

Conte SC, Pagan V, Murer B

Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: clinical, radiological and histological pattern.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 1997;52(1):24-6

Jessurun GA, Hoogenberg K, Crijns HJ

Bronchiolitis obliterans organizing pneumonia during low-dose amiodarone therapy.

Clinical cardiology. 1997;20(3):300-2

Valle JM, Alvarez D, Antúnez J, Valdés L

Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.

The European respiratory journal. 1995;8(3):470-1

Darmanata JI, van Zandwijk N, Düren DR, van Royen EA, Mooi WJ, Plomp TA, Jansen HM, Durrer D

Amiodarone pneumonitis: three further cases with a review of published reports.

Thorax. 1984;39(1):57-64

Camus P, Lombard JN, Perrichon M, Piard F, Guérin JC, Thivolet FB, Jeannin L

Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone.

Thorax. 1989;44(9):711-5